During the past decade, Northwest Louisiana Nephrology conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 10 clinical trials were completed, i.e. on average, 52.6% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 7 clinical trials were completed. i.e. 77.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwest Louisiana Nephrology" #1 sponsor was "Pfizer" with 3 trials, followed by "Reata Pharmaceuticals, Inc." with 3 trials sponsored, "Bayer" with 2 trials sponsored, "ChemoCentryx" with 2 trials sponsored and "Gilead Sciences" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Louisiana Nephrology" #1 collaborator was "Medpace, Inc." with 3 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Arkana Labs" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Kidney Research Network, formerly NephCure Accelerating Cures Institute" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Louisiana Nephrology" are "Chronic Kidney Disease" (5 trials), "Focal Segmental Glomerulosclerosis" (4 trials), "Autosomal Dominant Polycystic Kidney" (3 trials), "Diabetic Kidney Disease" (3 trials) and "IgA Nephropathy" (3 trials). Many other conditions were trialed in "Northwest Louisiana Nephrology" in a lesser frequency.

Most popular intervention types in "Northwest Louisiana Nephrology" are "Drug" (26 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "CCX140-B" (2 trials), "Epoetin Hospira" (2 trials), "Mycophenolate mofetil" (2 trials) and "vildagliptin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Louisiana Nephrology" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Northwest Louisiana Nephrology". 1 are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Northwest Louisiana Nephrology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Louisiana Nephrology, 3 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".